BridgeBio Pharma, Inc. BBIO

65.57 (0.71) (1.07%) as of 25 Sep
Market cap
$13.1B
P/E
0.0×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Cash and Short Term Investments
587.48 681.10 451.54 509.85 836.84 607.09 545.99 436.09 92.00
Receivables
139.44 4.72 1.75 17.08 19.75 — 2.85 — —
Inventory
26.75 — — — — — — — —
Total current assets
797.75 720.69 477.59 548.85 888.86 642.82 568.62 445.22 97.00
Property, Plant, Equpment (Net)
5.37 7.01 11.82 14.57 30.07 20.33 5.63 1.58 0.00
Long-Term Investments
79.97 143.75 — 3.00 2.00 3.00 31.14 17.05 0.00
Goodwill and Intangible Assets (Total)
28.08 23.93 26.32 28.71 44.93 — — — 0.00
Long-term assets (Other)
16.71 18.20 22.63 20.22 33.03 23.93 26.29 1.09 0.00
Total non-current assets
138.28 198.65 68.79 74.18 123.93 60.76 63.06 19.72 —
Total Assets
936.03 919.34 546.38 623.04 1,012.79 703.59 631.68 464.94 0.00
Accounts Payable
36.23 9.62 10.66 11.56 11.88 8.95 8.85 13.51 2.00
Accrued Expenses
118.14 92.60 122.97 98.04 87.97 62.55 36.44 14.73 —
Current Part of Debt
— — — 4.00 5.00 1.46 8.00 — —
Current Part of Capital Lease
— — — — — — — — 0.00
Current Part of Taxes to Pay
— — — — — — — — 0.00
Current Revenue (Deferred)
7.19 14.60 6.10 8.16 — — — — —
Other current liabilities
120.22 33.07 — 106.00 118.00 5.55 4.08 3.01 7.00
Total current liabilities
287.97 154.40 143.84 121.43 135.07 95.65 60.39 32.58 9.00
Long Term Debt (Total)
1,852.47 1,721.38 1,726.73 1,707.62 1,703.81 475.86 91.79 54.51 144.00
Non-current Revenue (Deferred)
13.08 17.10 3.73 — — — — — 0.00
Minority Interests
(0.57) 0.14 0.48 (1.59) 1.42 1.63 2.24 0.12 0.00
Non-current Liabilities (Other)
855.27 479.38 5.63 26.64 22.07 9.52 3.53 0.50 0.00
Total non-current liabilities
2,724.07 2,222.69 1,745.55 1,744.94 1,744.73 501.68 97.56 55.12 —
Total liabilities
3,012.04 2,377.09 1,889.39 1,866.37 1,879.79 597.33 157.95 87.70 0.00
Additional Paid In Capital
2,057.65 1,903.16 1,481.03 938.70 841.53 1,021.34 848.11 494.23 0.00
Preferred Stock (Total)
— — — — — — — — 0.00
Common Stock (Net)
0.20 0.20 0.18 0.16 0.15 0.13 0.12 0.09 0.00
Retained Earnings
(3,821.19) (3,096.26) (2,560.50) (1,918.15) (1,436.97) (888.75) (440.03) (179.44) (61.00)
Treasury Stock
323.28 275.00 275.00 275.00 275.00 75.00 — — 0.00
Shareholders Equity (Other)
— — — — — — — — 0.00
Common Equity (Total)
(2,076.01) (1,457.75) (1,343.01) (1,243.33) (867.00) 106.26 473.73 377.24 (61.00)
Shareholders Equity (Total)
(2,076.01) (1,457.75) (1,343.01) (1,243.33) (867.00) 106.26 473.73 377.24 0.00
Shareholders Equity and Liabilities (Total)
936.03 919.34 546.38 623.04 1,012.79 703.59 631.68 464.94 0.00
Shares (Common)
194.77 190.04 175.08 150.63 147.34 122.85 123.66 92.06 —
Shareholders Equity (Tangible)
(2,104.09) (1,481.68) (1,369.33) (1,272.05) (911.94) 106.26 473.73 377.24 —
Net Debt
1,264.99 1,040.28 1,275.19 1,201.76 871.97 (129.78) (446.20) (381.58) 52.00
Total Debt
1,852.47 1,721.38 1,726.73 1,711.62 1,708.81 477.32 99.79 54.51 144.00

Fold the line items

In millions of $ except per-share values · columns are period end dates